IBA Executive and Leadership Team

May, 2026

Leadership Overview

IBA Group has 4 executives leading key functions including strategy, finance, proton therapy, and operations.

Driven by innovation, IBA is dedicated to advancing particle accelerator technology for critical medical and industrial applications, focusing on improving health outcomes and enhancing lives globally.

Leadership Roles at IBA

  • Chief Executive Officer - Ikram Syed
  • Chief Financial Officer - Irwin Thomashow
  • President, Iba Proton Therapy (North America) - Mary Klein
  • President - Pr Costa
  • Ikram Syed - Chief Executive Officer

    Ikram Syed, the Chief Executive Officer at IBA, directs the company's overall strategic vision and operational execution. Syed guides IBA Group's global expansion, ensuring alignment with its mission to provide innovative particle accelerator solutions for medical and industrial sectors. This leadership involves overseeing the development and deployment of advanced equipment for cancer treatment and sterilization processes. Syed's focus remains on enhancing the company's market position and driving technological advancements that protect, enhance, and save lives worldwide. The Chief Executive Officer's responsibilities extend to fostering key partnerships and ensuring the long-term financial health and growth of the organization. Through strategic decision-making, Syed champions the company's commitment to improving health outcomes by supporting hospitals with cutting-edge technology. Ikram Syed's executive oversight ensures that IBA continues to lead in delivering life-saving and life-enhancing solutions across its diverse operational landscape.

    Irwin Thomashow - Chief Financial Officer

    Irwin Thomashow, the Chief Financial Officer at IBA, manages all financial aspects of the global organization. Thomashow oversees financial planning, risk management, and capital allocation to support IBA Group's strategic objectives in particle accelerator technology. This role involves ensuring fiscal responsibility across all divisions, including those focused on medical equipment for cancer diagnosis and treatment, and industrial sterilization applications. The Chief Financial Officer's duties include optimizing financial performance and driving profitability to fund ongoing research and development initiatives. Thomashow works closely with other executive leaders to secure the necessary resources for maintaining and upgrading advanced technology for hospitals worldwide. By implementing robust financial controls and strategies, Irwin Thomashow directly contributes to the company's capacity to protect, enhance, and save lives through its innovative solutions. The financial leadership provided ensures sustainable growth and operational efficiency.

    Mary Klein - President, Iba Proton Therapy (North America)

    Mary Klein, the President, Iba Proton Therapy (North America) at IBA, leads the strategic direction and operational management for the company's proton therapy division across the North American market. Klein drives the expansion and implementation of advanced cancer treatment solutions, ensuring IBA Group's technology effectively serves healthcare providers in the region. This leadership role involves overseeing sales, service, and support for proton therapy systems, directly impacting patient care and outcomes. The President, Iba Proton Therapy (North America)'s responsibilities include fostering strong relationships with hospitals and medical institutions to integrate cutting-edge equipment. Mary Klein's focus is on enhancing the accessibility and efficacy of IBA's life-saving technologies within North America. By managing regional operations, Klein ensures that the company's commitment to protecting, enhancing, and saving lives is realized through dedicated service and technological excellence in the critical field of oncology.

    Pr Costa - President

    Pr Costa, the President at IBA, directs key operational functions and strategic initiatives across the company's global business units. Costa oversees the integration of particle accelerator technology for both medical and industrial applications, ensuring seamless delivery of solutions that improve health outcomes and support industrial processes like sterilization. This leadership role involves driving operational efficiency and fostering innovation within the teams responsible for designing and producing advanced equipment. The President's responsibilities include ensuring that IBA Group maintains its position as a global leader by providing, maintaining, and upgrading technology for hospitals and industries worldwide. Pr Costa's executive oversight supports the company's core mission to protect, enhance, and save lives through reliable and advanced technological solutions. By managing critical operational aspects, Costa ensures the effective deployment of IBA's life-saving and life-enhancing products.

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding IBA Top Executives and Leadership Team

    Who leads IBA?
    IBA is led by Ikram Syed (Chief Executive Officer), along with executives such as Irwin Thomashow (Chief Financial Officer) and Mary Klein (President, Iba Proton Therapy (North America)).
    Who is part of IBA’s executive team?
    The executive team of IBA includes leaders such as Ikram Syed (Chief Executive Officer), Irwin Thomashow (Chief Financial Officer), Mary Klein (President, Iba Proton Therapy (North America)) and other senior executives.
    How many executives does IBA have?
    IBA has 4 executives leading key business areas.
    What roles are included in IBA’s leadership team?
    The leadership team of IBA includes roles such as Chief Executive Officer, Chief Financial Officer, President, Iba Proton Therapy (North America), President.